RE:this financingI think once nvestors digest what has happened they will realise that the sharp decline in the share price was not some kind of failure in the Company's objectives,
. Nothing has changed other than we have increased the shares outstanding by around 20% .
The actual operations of the Company continue to grow with many different uses for potential cures for cancer plus the increase in Sales that is expected with the core business.
The shares outstanding even with the 20% dilution will mean nothing if the Company is successful in finding cures for cancer......so at 40 cents a share and the plans that the Company has in place for 2015 , the excitement is still there and lets see what develops over the coming weeks and months.
But I have to agree I did not like the Company coming out with positive news when they had or were reaching an agreement for financing at 44cents a share.......not what any of us would have expected.
GLTA